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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comand subsequent impact on adverse events during Non-ST elevation myocardial
infarction (NSTEMI).
Methods: A total of 1,264 NSTEMI patients underwent PCI between 2009-2013.
GRACE scores were calculated post-hoc to assess high-risk (HR) vs. non high-risk
(non-HR) patients, and further analyzed according to revascularization time [early
revascularization (ER) 24 hrs or delayed (DR) >24 hrs]. To assess predictors of ER,
multivariate logistic models were constructed which included patient characteristics
upon presentation and GRACE score. Multivariate models were also created for effect
of ER on 6-month target vessel revascularization or major adverse cardiovascular
events (TVR-MACE) comprised of all-cause death or Q-wave MI.
Results: The majority (61%) of non-HR patients underwent ER, whereas the majority
(58%) of HR patients underwent DR. HR GRACE patients were 49% less likely to
undergo ER compared with non-HR (odds ratio [OR] 0.51, 95% CI 0.36-0.71; p <
0.001), despite their increased risk. Hemoglobin < 10g/dL (OR 0.33 [0.2-0.52] p <
0.001) and presentation year  2012 (OR 0.65 [0.5-0.86] p < 0.01) were also
associated with DR while magnitude of troponin change from baseline was associated
with ER (OR 1.02 [1.01-1.03] p ¼0.001). TVR-MACE at 6 months was signiﬁcantly
greater for HR than non-HR patients (34.9% vs. 11.4%, p < 0.001). However, E PCI
did not reduce events within either group; HR-delayed vs. early (35.1% vs. 34.6%,
hazard radio (HR) 1.10 [CI 0.64-1.88] p¼0.7) or non-HR delayed vs. early (10.2% vs.
12.1%, HR 1.73 [0.92-3.28] p ¼0.9).
Conclusions: Non-HR patients were more likely to receive ER than any other group,
possibly a result of lower procedural risk compared with HR patients and/or less
confounding associated conditions warranting attention prior to revascularization. A
clinician’s clinical gestalt appears to determine the most appropriate timing of
revascularization for patients with NSTEMI, unrelated to overall risk. This decision
does not translate into a difference in adverse events.
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Background: Early invasive approach (early coronary angiography [CAG] with
subsequent revascularization when necessary) is advocated in moderate- to high-risk
patients (pts) with acute coronary syndrome (ACS) to guide management. However,
whether beneﬁt of early invasive strategy exceeds the risk of bleeding in pts with ACS
and baseline anemia is not known. We therefore assessed impact of early CAG on
outcomes of pts with ACS and baseline anemia in the biennial Israeli ACS registry.
Methods: The study is based on the cumulative data from 3 consecutive surveys
conducted during 2006, 2008 and 2010. Rates of TIMI major bleeding, 30-day MACE
and 1-year mortality were analyzed.
Results: Among a total of 5600 pts with ACS, anemia at baseline was present in 1464
pts (26.1%). Early CAG was performed in 4877 pts (87.1%), including 1122 pts
(76.6%) with baseline anemia and 3755 pts (90.8%) without baseline anemia (p<
0.001). Non-performance of CAG was associated with older age, higher prevalence of
comorbidities and higher GRACE risk score. Among pts with anemia in whom CAG
was performed, the majority of pts (1071; 95.5%) had obstructive CAD of whom
73.1% were triaged to PCI, 22.2% were treated medically, and 4.7% were referred for
CABG. Clinical outcomes are presented in the Table. After adjustment for potential
covariates, performance of early CAG was associated with lower 1-year mortality (HR
[95% CI]¼0.43 [0.31-0.60], p< 0.001) without increase in major bleeding (OR [95%
CI]¼1.29 [0.55, 3.05], p¼0.55).
Conclusions: In the non-selected patients with ACS, anemia at baseline was present in
every 4th patient. Pts with ACS and baseline anemia were less likely to be managed
with early invasive approach. Despite the presence of baseline anemia, early coronary
angiography with subsequent revascularization when appropriate was associated with
improved 30-day and 1-year survival without an increase in rates of major bleeding.Outcomes,
n (%)
Patients with ACS and baseline anemia
n ¼ 1,464
P value
Coronary angiogram (+)
n ¼ 1,122
Coronary angiogram (-)
n ¼ 342
At 30 days
Death 64 (5.7) 53 (15.6) <0.0001
Reinfarction 41 (3.7) 10 (2.9%) 0.52
Stroke 6 (0.5) 4 (1.2) 0.21
Major bleeding 35 (3.1) 13 (3.8) 0.54
MACE* 99 (8.8) 62 (18.1) <0.0001
At 1 year
Death 133 (11.9) 116 (34.1) <0.0001
*Death, reinfarction or stroke
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Background: Positive T-wave amplitude in lead aVR has been shown to be associ-
ated with the presence of multi-vessel disease and worse clinical outcome in patients
with ST elevation myocardial infarction, although its effects on patients with non-ST
elevation myocardial infarction (NSTEMI) has not been fully explored. We aimed to
investigate the impact of positive T-wave amplitude in lead aVR on clinical outcomes
in NSTEMI patients.
Methods: 340 NSTEMI patients who presented during 2013 were retrospectively
reviewed. Electrocardiograms were interpreted in a blinded fashion; Positive T-wave
(PTw) was deﬁned as T-wave amplitude > 0 mV and Negative T-wave (NTw) was
deﬁned as T-wave amplitude & 0 mV in lead aVR. Patients were divided into two
groups; PTw and NTw. Angiograms were reviewed in a blinded fashion. Multi-ter-
ritorial ischemia was diagnosed based on the clinical and angiographic ﬁndings when
there is greater than 90% stenosis in more than two coronary arteries. The rate of in-
hospital revascularization procedures including percutaneous coronary intervention
(PCI) and coronary artery bypass graft (CABG) as well as in-hospital major adverse
cardiac event (MACE) including death, recurrent myocardial infarction, target vessel
revascularization, and lethal ventricular arrhythmias were compared between the two
groups.
Results: Among 340 patients, 67 patients (19.7%) had PTw and 273 (80.3%) had
NTw. Patients with PTw were more likely to have diabetes mellitus (49.2% vs. 32.6%,
p¼0.001) and hypertension (88.1 % vs. 71.8%, p¼0.006). Though there was no
signiﬁcant difference in the rate of multi-vessel disease between the two groups,
patients with PTw had a higher rate of multi-territorial ischemia (31.3% vs. 15.4%, p¼
0.003) compared to patients with NTw. The presence of PTw was associated with a
higher rate of in-hospital CABG (13.4% vs. 5.9%, p¼ 0.033) and a lower rate of in-
hospital PCI (32.8% vs. 55.3%, p¼0.001). There was no statistical difference between
the two groups in the rate of in-hospital MACE (1.5% vs. 2.2%, p¼ 0.716).
Conclusions: Positive T-wave amplitude in lead aVR was signiﬁcantly associated
with a higher rate of multi-territorial ischemia and in-hospital CABG in patients with
NSTEMI.
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Background: Prolonged QTc interval has been shown to have a predictive value for
major adverse cardiac event including death, recurrent ischemia, and urgent coronary
revascularization in non-ST elevation acute coronary syndrome. However, little is
known about the correlation between prolonged QTc interval and the incidence of
heart failure.
Methods: We retrospectively reviewed 292 consecutive NSTEMI patients who pre-
sented with chest pain and underwent coronary angiography within ﬁve days after
presentation from January 2013 to December 2013. Of the 292 patients, 19 patients
with atrial ﬁbrillation or paced rhythm were excluded. Electrocardiography and cor-
onary angiography were reviewed by a blind fashion. QTc prolongation was deﬁned
as QTc greater than 450ms in men and 470ms in women. The rate of in-hospital
percutaneous or surgical revascularization and in-hospital major adverse cardiac event
(MACE) including death, recurrent myocardial infarction, target vessel revasculari-
zation, lethal ventricular arrhythmias and heart failure deﬁned by Killip classS2, were
recorded. Clinical characteristics alongside electrocardiographic and angiographic
ﬁndings were compared between the patients with and without prolonged QTc
interval.
Results: Among 273 patients, 93 patients (34.1%) had prolonged QTc interval. Pa-
tients with prolonged QTc interval were more likely to have hypertension and prior
myocardial infarction than those with normal QTc interval. Patients with prolonged
QTc interval had a higher rate of in-hospital MACE (21.5% vs. 5.0%, p< 0.001),
driven by four-fold increase of heart failure (19.4% vs. 3.9%, p< 0.001). However,
there was no signiﬁcant difference in the rate of percutaneous or surgical revascu-
larization or impaired coronary blood ﬂow between the two groups. The association
between prolonged QTc interval and in-hospital heart failure persisted after adjusting
for hypertension and prior myocardial infarction (odds ratio 5.81; 95% conﬁdence
interval, 2.36 to 15.8; P< 0.001).
Conclusions: Prolonged QTc interval was commonly observed in patients with
NSTEMI, and was an independent predictor of in-hospital heart failure.3–17, 2014 j TCT Abstracts/Acute Coronary Syndromes (non STEMI)
